0.6637
Schlusskurs vom Vortag:
$0.7097
Offen:
$0.681
24-Stunden-Volumen:
119.70K
Relative Volume:
0.12
Marktkapitalisierung:
$12.77M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-24.05M
KGV:
-0.3087
EPS:
-2.15
Netto-Cashflow:
$-17.78M
1W Leistung:
-7.04%
1M Leistung:
-31.44%
6M Leistung:
-81.30%
1J Leistung:
-80.42%
Envveno Medical Corporation Stock (NVNO) Company Profile
Firmenname
Envveno Medical Corporation
Sektor
Branche
Telefon
949-261-2900
Adresse
70 DOPPLER, IRVINE
Vergleichen Sie NVNO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
NVNO
Envveno Medical Corporation
|
0.6637 | 14.35M | 0 | -24.05M | -17.78M | -2.15 |
|
ABT
Abbott Laboratories
|
125.51 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.50 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
363.07 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.10 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
84.04 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
Envveno Medical Corporation Aktie (NVNO) Neueste Nachrichten
Will enVVeno Medical Corporation (5HJ) stock profit from fiscal stimulusJuly 2025 Market Mood & Real-Time Volume Trigger Notifications - newser.com
Can enVVeno Medical Corporation stock maintain growth trajectoryOptions Play & Safe Capital Investment Plans - newser.com
Visualizing enVVeno Medical Corporation stock with heatmaps2025 Technical Patterns & Fast Entry Momentum Alerts - newser.com
How to use a screener to detect enVVeno Medical Corporation breakouts2025 Geopolitical Influence & Fast Entry Momentum Trade Alerts - newser.com
enVVeno Medical Corporation stock prediction for this weekWeekly Stock Analysis & Risk Managed Investment Strategies - newser.com
Quantitative breakdown of enVVeno Medical Corporation recent moveForecast Cut & Stock Market Timing Techniques - newser.com
Why analysts maintain buy rating on enVVeno Medical Corporation (5HJ) stockBear Alert & Safe Entry Point Identification - newser.com
Published on: 2025-11-03 07:21:33 - newser.com
Price momentum metrics for enVVeno Medical Corporation explained2025 Volatility Report & Stock Portfolio Risk Control - newser.com
What Wall Street predicts for enVVeno Medical Corporation stock priceTrade Risk Assessment & Free High Return Stock Watch Alerts - newser.com
Tools to monitor enVVeno Medical Corporation recovery probabilityJuly 2025 Market Mood & Fast Exit Strategy with Risk Control - newser.com
Can enVVeno Medical Corporation stock deliver strong Q4 earningsMarket Performance Recap & Real-Time Volume Surge Alerts - newser.com
enVVeno Medical Corporation stock trend forecast2025 Volatility Report & Free Technical Confirmation Trade Alerts - newser.com
Detecting support and resistance levels for enVVeno Medical Corporation2025 Price Momentum & AI Forecasted Entry and Exit Points - newser.com
Comparing enVVeno Medical Corporation in custom built stock radarsMarket Trend Review & Fast Exit Strategy with Risk Control - newser.com
Will enVVeno Medical Corporation (5HJ) stock justify high valuation2025 Technical Patterns & Smart Investment Allocation Insights - newser.com
Can enVVeno Medical Corporation stock sustain market leadershipWeekly Trade Summary & Growth Oriented Trading Recommendations - newser.com
Will enVVeno Medical Corporation (5HJ) stock benefit from Fed rate cuts2025 Key Lessons & AI Driven Stock Price Forecasts - newser.com
enVVeno Medical Launches $50M Equity Offering Program - The Globe and Mail
enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Lelezard
enVVeno Medical reports Q3 EPS (23c) vs. (35c) last year - MSN
NVNO: Financial Stability as FDA Discussions Progress - GuruFocus
enVVeno Medical (NASDAQ: NVNO) funds operations through Q2 2027; cash $31.0M - Stock Titan
Finanzdaten der Envveno Medical Corporation-Aktie (NVNO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):